Inhibition of polymorphonuclear cells averts cytotoxicity against hypoimmune cells in xenotransplantation
Xiaomeng Hu, Grigol Tediashvili, Alessia Gravina, Jonathan Stoddard et autres
8 citationsNature Communications
Alessia Gravina
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
63Publications signalées
2718Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and ManagementAdipokines, Inflammation, and Metabolic DiseasesMetabolism, Diabetes, and CancerPluripotent Stem Cells Research
Publications récentes
1006P Phase I dose escalation study of HFB200603, a best-in-class BTLA antagonist monoclonal antibody (mAb), in monotherapy and in combination with the anti-PD-1 mAb tislelizumab (TIS) in adult patients (pts) with advanced solid tumors
M. De Miguel, A. Landa Magdalena, V. Gambardella, Jessica Menis et autres
3 citationsAnnals of Oncology
Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicity
Alessia Gravina, Grigol Tediashvili, Yueting Zheng, Kumiko A. Iwabuchi et autres
31 citationsCell stem cell
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial
Erica Matino, Elena Tavella, Manuela Rizzi, Gian Carlo Avanzi et autres
27 citationsNutrients
Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression
Alessia Gravina, Grigol Tediashvili, Raja Rajalingam, Zoe Quandt et autres
48 citationsNature Biotechnology
Author Correction: Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients
T. Deuse, Xiaomeng Hu, Alessia Gravina, Dong Wang et autres
5 citationsNature Biotechnology
Hypoimmune induced pluripotent stem cell–derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice
T. Deuse, Grigol Tediashvili, Xiaomeng Hu, Alessia Gravina et autres
57 citationsProceedings of the National Academy of Sciences
CRIPSR/Cas9 Technology: Hypoimmunogenic Pluripotent Stem Cells Evade Immune Rejection in Fully Immunocompetent Allogeneic Recipients
Xiaomeng Hu, T. Deuse, Alessia Gravina, D. Wang et autres
2 citationsThe Journal of Heart and Lung Transplantation
The SIRPα–CD47 immune checkpoint in NK cells
T. Deuse, Xiaomeng Hu, Sean Agbor-Enoh, Moon Kyoo Jang et autres
211 citationsThe Journal of Experimental Medicine
HYPOIMMUNOGENIC DERIVATIVES OF INDUCED PLURIPOTENT STEM CELLS EVADE IMMUNE REJECTION IN FULLY IMMUNOCOMPETENT ALLOGENEIC RECIPIENTS
Xiaomeng Hu, T. Deuse, Alessia Gravina, Dong Wang et autres
0 citationsTransplantation
The H-Y Antigen in Embryonic Stem Cells Causes Rejection in Syngeneic Female Recipients
Xiaomeng Hu, S.T. Kueppers, Nigel G. Kooreman, Alessia Gravina et autres
9 citationsStem Cells and Development
Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients
Dong Wang, Lewis L. Lanier, Angela Wahl, Hermann Reichenspurner et autres
0 citationsCarolina Digital Repository (University of North Carolina at Chapel Hill)
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.